Endo, Inc. recalls
2 notices naming Endo, Inc. as the recalling firm, since November 21, 2024. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors
Hazard (FDA): Product is an unapproved drug.
FDAMedicines
Mislabeled
Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Due to Potential Product Carton Strength Mislabeling
Hazard (FDA): Mislabeled with the incorrect strength on the carton
FDAMedicines